Latest News

April 2012: Co-founder Yosef Refaeli, Ph.D., speaks frankly with Fast Company about challenges facing early-stage biotech startups and how Taiga is overcoming those challenges. Read the article.

June 2011: Margaret Jackson of the Denver Post writes about Taiga Biotechnologies' Red Blood Cell Pharming Program, outlining the medical need and highlighting the benefits of the recent efforts including the ability to grow a universal donor supply of red blood cells. Read the article.

January 2011: Co-founders Dr. Brian Turner and Dr. Yosef Refaeli are interviewed for a recent article in Life Science Leader written by Gail Dutton about the challenges of raising seed capital. Read the article.

Taiga Biotechnologies Awarded Three New NIH SBIR Grants; With Previous Grants, Total SBIR Funding Received is Over $2.1 Million. Press Release

Taiga’s Scientific Advisory Board Chairman, Yosef Refaeli, is featured in a Nature article about the growing bioscience industry in the Denver area. Read the article.

March 1, 2010: Taiga Biotechnologies, Inc. received its third small business innovation research grant from the Department of Health and Human Services, National Institute of Allergy and Infectious Disease. The grant will be used to further develop the proprietary technology for improving vaccines for infectious disease and cancer with a new adjuvant product called TBI-4000. Read the abstract.

Taiga's technology and its applications featured in University of Colorado Cancer Center Quarterly Update.

Taiga’s Scientific Advisory Board Chairman, Yosef Refaeli, to present Taiga’s technology platform at Americas Antibody Congress 2009. September 21-23. Washington, D.C.

August 7, 2008: Taiga Biotechnologies, Inc. received its first small business innovation research grant from the Department of Health and Human Services, National Institute of Allergy and Infectious Disease. The grant will be used to further develop technology to rapidly generate human therapeutic antibodies against influenza.

June 24, 2008: International reports by Forbes, U.S. News and World Report and others describe recent lymphoma discovery made by Taiga founders.
Forbes | U.S. News and World Report

Local CBS news conducts an exclusive interview with Dr. Yosef Refaeli about the stem cell technology discovered at National Jewish Medical and Research Center.
The following link contains the entire interview which aired on CBS channel 4 on Tuesday, November 27, 2007. Watch video.